Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

NCT07362017 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vanda Pharmaceuticals